IP Library › Assignment 074194/0909
Patent Assignment
Reel/Frame 074194/0909

Assignment of Assignor's Interest

Recorded: 2026-03-26 Pages: 12
Assignor
ZEVRA THERAPEUTICS, INC.
Executed: 2026-03-13
Assignee
COMMAVE THERAPEUTICS SA
AVENUE GIUSEPPE-MOTTA 31-37, GENÈVE, 1202, SWITZERLAND
Covered Properties (5)
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Application: 61/512,658 →
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Patent: 9,079,928 →
Application: 14/234,440 →
Publication: US 2014/0243291
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Patent: 9,453,037 →
Application: 14/727,498 →
Publication: US 2015/0266911
Methylphenidate-Prodrugs, Processes of Making and Using the Same
Application: 15/249,088 →
Publication: US 2017/0049765
Methylphenidate-Oxoacid Conjugates, Processes of Making and Using the Same
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2012
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 029078/0013 →
Assignment of Assignor's Interest Apr 25, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 032755/0674 →
Security Interest Jun 3, 2014
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 033079/0927 →
Assignment of Assignor's Interest Aug 21, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 033580/0775 →
Corrective Assignment to Correct the Doc Date for Guochen Chi and Doc Date for Bindu Bera Previously Recorded on Reel 033580 Frame 0775. Assignor(S) Hereby Confirms the Doc Date Guochen Chi 03/27/2014 and Doc Date for Bindu Bera 03/24/2014. Aug 28, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 033648/0173 →
Assignment of Assignor's Interest Oct 22, 2014
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 034007/0354 →
Assignment of Assignor's Interest Jan 20, 2016
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; BERA, SANJIB
To: KEMPHARM, INC.
Reel/Frame 037531/0211 →
Assignment of Assignor's Interest Nov 14, 2016
From: GUENTHER, SVEN; MICKLE, TRAVIS; CHI, GUOCHEN; BERA, BINDU
To: KEMPHARM, INC.
Reel/Frame 040312/0818 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2018
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 047320/0697 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 037531 Frame: 0375. Assignor(S) Hereby Confirms the Assignment. Sep 5, 2018
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 047021/0469 →
Security Interest Feb 28, 2020
From: KEMPHARM, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 051968/0714 →
Release of Security Interest Jul 9, 2021
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.
To: KEMPHARM, INC.
Reel/Frame 056803/0133 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 033648 Frame: 0173. Assignor(S) Hereby Confirms the Assignment. Aug 26, 2021
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 057322/0436 →
Corrective Assignment to Correct the Assignee's Address on the Assignment Document Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment . Oct 19, 2021
From: GUENTHER, SVEN; CHI, GUOCHEN; BERA, BINDU; MICKLE, TRAVIS
To: KEMPHARM, INC.
Reel/Frame 057848/0159 →
Change of Name Feb 26, 2024
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 066679/0668 →
Security Interest Apr 8, 2024
From: ZEVRA THERAPEUTICS, INC.
To: ALTER DOMUS (US) LLC
Reel/Frame 067040/0637 →
Release of Security Interest Mar 13, 2026
From: ALTER DOMUS (US) LLC
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 075080/0907 →
Change of Name Mar 25, 2026
From: KEMPHARM, INC.
To: ZEVRA THERAPEUTICS, INC.
Reel/Frame 075243/0008 →
Assignment of Assignor's Interest Mar 25, 2026
From: ZEVRA THERAPEUTICS, INC.
To: COMMAVE THERAPEUTICS SA
Reel/Frame 074186/0531 →